OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
Rita Basu, Mazen Noureddin, Jeanne M. Clark
Mayo Clinic Proceedings (2022) Vol. 97, Iss. 9, pp. 1700-1716
Open Access | Times Cited: 34
Rita Basu, Mazen Noureddin, Jeanne M. Clark
Mayo Clinic Proceedings (2022) Vol. 97, Iss. 9, pp. 1700-1716
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States
Pegah Golabi, James M. Paik, Ameeta Ravi Kumar, et al.
Metabolism (2023) Vol. 146, pp. 155642-155642
Closed Access | Times Cited: 43
Pegah Golabi, James M. Paik, Ameeta Ravi Kumar, et al.
Metabolism (2023) Vol. 146, pp. 155642-155642
Closed Access | Times Cited: 43
MASH clinical trials and drugs pipeline: An impending tsunami
Mazen Noureddin
Hepatology (2024)
Closed Access | Times Cited: 16
Mazen Noureddin
Hepatology (2024)
Closed Access | Times Cited: 16
Management of metabolic-associated fatty liver disease: The diabetology perspective
Mohammad Sadiq Jeeyavudeen, Shahanas K A Khan, Sherouk Fouda, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 126-143
Open Access | Times Cited: 32
Mohammad Sadiq Jeeyavudeen, Shahanas K A Khan, Sherouk Fouda, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 126-143
Open Access | Times Cited: 32
Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges
Haoyu Tian, Shuairan Zhang, Ying Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4583-4583
Open Access | Times Cited: 21
Haoyu Tian, Shuairan Zhang, Ying Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4583-4583
Open Access | Times Cited: 21
A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis
Li Hu, Mingjie Wang, Peizhan Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116617-116617
Open Access | Times Cited: 5
Li Hu, Mingjie Wang, Peizhan Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116617-116617
Open Access | Times Cited: 5
Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: A cause for concern!
Akash Batta, Juniali Hatwal
World Journal of Cardiology (2024) Vol. 16, Iss. 7, pp. 380-384
Open Access | Times Cited: 5
Akash Batta, Juniali Hatwal
World Journal of Cardiology (2024) Vol. 16, Iss. 7, pp. 380-384
Open Access | Times Cited: 5
Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease: pathophysiology and diagnostic aspects
Søren Møller, Nina Kimer, Jens D. Hove, et al.
European Journal of Preventive Cardiology (2025)
Closed Access
Søren Møller, Nina Kimer, Jens D. Hove, et al.
European Journal of Preventive Cardiology (2025)
Closed Access
The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment
Eleni Michalopoulou, J Thymis, Stamatios Lampsas, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 428-428
Open Access
Eleni Michalopoulou, J Thymis, Stamatios Lampsas, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 428-428
Open Access
Association between SPISE and NAFLD in patients with type 2 diabetes
Hongyan Zhao, Baolan Ji, Xin Wang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Hongyan Zhao, Baolan Ji, Xin Wang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Changes in m6A in Steatotic Liver Disease
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Mohamed El‐Kassas, Abeer Awad, Mohamed Elbadry, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 01, pp. 054-068
Closed Access | Times Cited: 3
Mohamed El‐Kassas, Abeer Awad, Mohamed Elbadry, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 01, pp. 054-068
Closed Access | Times Cited: 3
Elevated LDL-c may warn of the risk of gallbladder stones in the patients with metabolic dysfunction-associated steatotic liver disease: A case-control study
Guifen Zhao, Ran‐Geng Shi, Mao Ma, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 6, pp. 102363-102363
Closed Access | Times Cited: 3
Guifen Zhao, Ran‐Geng Shi, Mao Ma, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 6, pp. 102363-102363
Closed Access | Times Cited: 3
Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease
Aleksandra Bołdys, Łukasz Bułdak, Mateusz Maligłówka, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1789-1789
Open Access | Times Cited: 9
Aleksandra Bołdys, Łukasz Bułdak, Mateusz Maligłówka, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1789-1789
Open Access | Times Cited: 9
Impairment of patient‐reported outcomes among patients with non‐alcoholic fatty liver disease: a registry‐based study
Yusuf Yılmaz, Ahmet Eren Toraman, Ceyda Alp, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 2, pp. 215-223
Closed Access | Times Cited: 14
Yusuf Yılmaz, Ahmet Eren Toraman, Ceyda Alp, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 2, pp. 215-223
Closed Access | Times Cited: 14
A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis
Miguel Suárez, Raquel Martínez, Ana María Torres, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 9, pp. 3801-3809
Closed Access | Times Cited: 8
Miguel Suárez, Raquel Martínez, Ana María Torres, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 9, pp. 3801-3809
Closed Access | Times Cited: 8
Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders.
Habib Yaribeygi, Mina Maleki, Tannaz Jamialahmadi, et al.
PubMed (2023) Vol. 22, pp. 403-414
Closed Access | Times Cited: 5
Habib Yaribeygi, Mina Maleki, Tannaz Jamialahmadi, et al.
PubMed (2023) Vol. 22, pp. 403-414
Closed Access | Times Cited: 5
Different dietary carbohydrate component intakes and long-term outcomes in patients with NAFLD: results of longitudinal analysis from the UK Biobank
Zhening Liu, Hangkai Huang, Jiarong Xie, et al.
Nutrition Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Zhening Liu, Hangkai Huang, Jiarong Xie, et al.
Nutrition Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Novel Noninvasive Paraclinical Study Method for Investigation of Liver Diseases
Nina Gyorfi, Adrián Róbert Gál, András Fincsúr, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2449-2449
Open Access | Times Cited: 3
Nina Gyorfi, Adrián Róbert Gál, András Fincsúr, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2449-2449
Open Access | Times Cited: 3
Global research on portal vein thrombosis and liver transplantation: A bibliometric and visualized study
Ling Zhong, Ting-Ting Ren, Lei Shi, et al.
Medicine (2023) Vol. 102, Iss. 32, pp. e34497-e34497
Open Access | Times Cited: 2
Ling Zhong, Ting-Ting Ren, Lei Shi, et al.
Medicine (2023) Vol. 102, Iss. 32, pp. e34497-e34497
Open Access | Times Cited: 2
The therapeutic mechanisms and beneficial effects of ursodeoxycholic acid in the treatment of nonalcoholic fatty liver disease: a systematic review
Sorina Ionelia Stan, Viorel Biciușcă, Diana Clenciu, et al.
Medicine and Pharmacy Reports (2023) Vol. 97, Iss. 1, pp. 12-25
Open Access | Times Cited: 2
Sorina Ionelia Stan, Viorel Biciușcă, Diana Clenciu, et al.
Medicine and Pharmacy Reports (2023) Vol. 97, Iss. 1, pp. 12-25
Open Access | Times Cited: 2
Not only baseline but cumulative exposure of remnant cholesterol predicts the development of nonalcoholic fatty liver disease: a cohort study
Lei Liu, Changfa Wang, Zhongyang Hu, et al.
Environmental Health and Preventive Medicine (2024) Vol. 29, pp. 5-5
Open Access
Lei Liu, Changfa Wang, Zhongyang Hu, et al.
Environmental Health and Preventive Medicine (2024) Vol. 29, pp. 5-5
Open Access
Management of dyslipidemia in special groups
P B Jayagopal, Prafulla Kerkar
Indian Heart Journal (2024) Vol. 76, pp. S96-S100
Open Access
P B Jayagopal, Prafulla Kerkar
Indian Heart Journal (2024) Vol. 76, pp. S96-S100
Open Access
O papel de neutrófilos PD-L1+ durante a hiperinflamação nas doenças hepáticas gordurosas não alcoólicas
Cleyson da Cruz Oliveira Barros
(2024)
Open Access
Cleyson da Cruz Oliveira Barros
(2024)
Open Access
Efficacy of Ayurveda interventions and lifestyle versus lifestyle interventions alone in grade I and II non-alcoholic fatty liver disease: Protocol for a multicenter exploratory pilot randomized controlled trial
Banamali Das, Seema Jain, S. Krishna Rao, et al.
Journal of Research in Ayurvedic Sciences (2024) Vol. 8, Iss. 4, pp. 201-208
Closed Access
Banamali Das, Seema Jain, S. Krishna Rao, et al.
Journal of Research in Ayurvedic Sciences (2024) Vol. 8, Iss. 4, pp. 201-208
Closed Access
A social media listening study of patients’ experiences relating to metabolic dysfunction-associated steatotic liver disease: the LISTEN-MASLD study
Jeffrey V. Lazarus, William Alazawi, Ron Basuroy, et al.
Annals of Hepatology (2024) Vol. 30, Iss. 1, pp. 101741-101741
Open Access
Jeffrey V. Lazarus, William Alazawi, Ron Basuroy, et al.
Annals of Hepatology (2024) Vol. 30, Iss. 1, pp. 101741-101741
Open Access
